To include your compound in the COVID-19 Resource Center, submit it here.

Tesetaxel: Phase I started

Genta began an open-label, Japanese Phase I trial

Read the full 86 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE